Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ASTRUM-005: The first immunotherapy clinical study of SCLC published in JAMA, one of the top medical journals in the world 2022-09-28 21:00
ICHNOS SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN STUDY FOR ISB 1442 2022-09-28 20:30
ABILITY DIABETES GLOBAL - A Landmark RCT in the field of PCI for patients with DM, completes Enrolment 2022-09-28 20:29
Advanced Instruments Introduces Solentim VIPS™ PRO, A High Efficiency Single Cell Seeder to Optimize Cell Line Development Workflows 2022-09-28 20:05
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts 2022-09-28 19:00
The IND application of Biosyngen BRG01 Therapy was accepted by CDE 2022-09-28 18:05
Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost 2022-09-28 17:34
New GHA Certification Helps Medical Tourism Facilitators Build Patient Trust 2022-09-28 17:00
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology 2022-09-28 16:00
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib 2022-09-28 13:00
Chugai Pharma Taiwan Awarded at the Asia Responsible Enterprise Awards 2022 for 'Cycling for Charity' under Social Empowerment Category 2022-09-28 12:30
ETANA HAS SECURED B ROUND FINANCING 2022-09-28 09:00
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure 2022-09-28 08:10
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate 2022-09-28 06:50
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent 2022-09-28 05:00
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
Neurophth announces first patient dosed in Phase III clinical trial for the gene therapy treatment of LHON 2022-09-27 20:30
Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study 2022-09-27 19:57
TargEDys and Inoliva announce they have entered a distribution partnership to bring Satylia® to Turkey 2022-09-27 17:15
Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China 2022-09-27 08:30
1 205 206 207 208 209 895